Barclays’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3K | Sell |
391
-4,478
| -92% | -$34.4K | ﹤0.01% | 4248 |
|
|
2025
Q1 | $41K | Sell |
4,869
-2,439
| -33% | -$20.5K | ﹤0.01% | 3942 |
|
|
2024
Q4 | $262K | Sell |
7,308
-12,473
| -63% | -$447K | ﹤0.01% | 3393 |
|
|
2024
Q3 | $934K | Buy |
19,781
+4,872
| +33% | +$230K | ﹤0.01% | 2654 |
|
|
2024
Q2 | $750K | Sell |
14,909
-1,460
| -9% | -$73.4K | ﹤0.01% | 2281 |
|
|
2024
Q1 | $1.83M | Buy |
16,369
+10,286
| +169% | +$1.15M | ﹤0.01% | 1999 |
|
|
2023
Q4 | $352K | Buy |
6,083
+4,717
| +345% | +$273K | ﹤0.01% | 3211 |
|
|
2023
Q3 | $43K | Sell |
1,366
-6,111
| -82% | -$192K | ﹤0.01% | 3657 |
|
|
2023
Q2 | $614K | Sell |
7,477
-444
| -6% | -$36.5K | ﹤0.01% | 2470 |
|
|
2023
Q1 | $815K | Sell |
7,921
-1,363
| -15% | -$140K | ﹤0.01% | 2282 |
|
|
2022
Q4 | $1.36M | Buy |
9,284
+3,855
| +71% | +$565K | ﹤0.01% | 1901 |
|
|
2022
Q3 | $918K | Buy |
5,429
+4,066
| +298% | +$688K | ﹤0.01% | 2201 |
|
|
2022
Q2 | $157K | Sell |
1,363
-300
| -18% | -$34.6K | ﹤0.01% | 3262 |
|
|
2022
Q1 | $166K | Sell |
1,663
-1,942
| -54% | -$194K | ﹤0.01% | 3426 |
|
|
2021
Q4 | $561K | Buy |
3,605
+2,284
| +173% | +$355K | ﹤0.01% | 2483 |
|
|
2021
Q3 | $312K | Sell |
1,321
-974
| -42% | -$230K | ﹤0.01% | 2795 |
|
|
2021
Q2 | $778K | Sell |
2,295
-2,722
| -54% | -$923K | ﹤0.01% | 2251 |
|
|
2021
Q1 | $2.03M | Buy |
5,017
+4,192
| +508% | +$1.7M | ﹤0.01% | 1842 |
|
|
2020
Q4 | $549K | Sell |
825
-332
| -29% | -$221K | ﹤0.01% | 2279 |
|
|
2020
Q3 | $538K | Buy |
1,157
+31
| +3% | +$14.4K | ﹤0.01% | 2270 |
|
|
2020
Q2 | $659K | Buy |
1,126
+88
| +8% | +$51.5K | ﹤0.01% | 2169 |
|
|
2020
Q1 | $151K | Sell |
1,038
-692
| -40% | -$101K | ﹤0.01% | 2661 |
|
|
2019
Q4 | $248K | Buy |
1,730
+561
| +48% | +$80.4K | ﹤0.01% | 3070 |
|
|
2019
Q3 | $46K | Buy |
1,169
+37
| +3% | +$1.46K | ﹤0.01% | 3701 |
|
|
2019
Q2 | $115K | Buy |
1,132
+590
| +109% | +$59.9K | ﹤0.01% | 3512 |
|
|
2019
Q1 | $71K | Buy |
542
+365
| +206% | +$47.8K | ﹤0.01% | 3498 |
|
|
2018
Q4 | $18K | Sell |
177
-190
| -52% | -$19.3K | ﹤0.01% | 3416 |
|
|
2018
Q3 | $92K | Buy |
367
+262
| +250% | +$65.7K | ﹤0.01% | 3460 |
|
|
2018
Q2 | $46K | Sell |
105
-65
| -38% | -$28.5K | ﹤0.01% | 3314 |
|
|
2018
Q1 | $68K | Buy |
170
+138
| +431% | +$55.2K | ﹤0.01% | 3342 |
|
|
2017
Q4 | $13K | Sell |
32
-120
| -79% | -$48.8K | ﹤0.01% | 3791 |
|
|
2017
Q3 | $66K | Buy |
+152
| New | +$66K | ﹤0.01% | 2850 |
|